Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 05, 2021

SELL
$56.65 - $64.55 $3.4 Million - $3.87 Million
-60,000 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $1.45 Million - $1.68 Million
-20,000 Reduced 25.0%
60,000 $4.62 Million
Q4 2019

Jan 27, 2020

SELL
$61.62 - $67.78 $308,100 - $338,900
-5,000 Reduced 5.88%
80,000 $5.2 Million
Q3 2019

Oct 30, 2019

SELL
$62.51 - $69.0 $125,020 - $138,000
-2,000 Reduced 2.3%
85,000 $5.39 Million
Q1 2019

Apr 25, 2019

SELL
$62.53 - $70.05 $1.25 Million - $1.4 Million
-20,000 Reduced 18.69%
87,000 $5.66 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $7.72 Million - $9.15 Million
107,000
107,000 $8.67 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Pacific Heights Asset Management LLC Portfolio

Follow Pacific Heights Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Heights Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Heights Asset Management LLC with notifications on news.